3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow FX006: new trials by email Literature Review of FX006 trials Research Report on FX006
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee FX006 32 mg - Osteoarthritis, Knee | Phase 3 | Completed | Pacira Pharmaceuticals, Inc | 129 | 2018-04-24 | 2024-01-24 |
| Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee FX006 32 mg - Osteoarthritis of the Knee | Phase 3 | Completed | Pacira Pharmaceuticals, Inc | 208 | 2017-02-20 | 2024-01-24 |
| Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee FX006, Placebo, TCA IR 40 - Osteoarthritis of the Knee | Phase 3 | Completed | Pacira Pharmaceuticals, Inc | 486 | 2015-01-01 | 2024-01-24 |
Osteoarthritis (3) · Osteoarthritis, Knee (3) · Pain (3)
Pacira Pharmaceuticals, Inc (3)
United States (3) · Australia (1) · Canada (1) · Denmark (1) · Estonia (1) · Hong Kong (1) · Lithuania (1) · Romania (1) · United Kingdom (1)
Scott Kelley, MD (2) · Neil Bodick, MD (1)